Comparison Of Isoconazole Nitrate Versus Nystatin For The Treatment Of Otomycosis

Amna Kausar, Sadia Chaudhry, Nighat Qammar, A. Akram, Ashar Alamgir, Wajid Hussain
{"title":"Comparison Of Isoconazole Nitrate Versus Nystatin For The Treatment Of Otomycosis","authors":"Amna Kausar, Sadia Chaudhry, Nighat Qammar, A. Akram, Ashar Alamgir, Wajid Hussain","doi":"10.37939/jrmc.v27i3.2372","DOIUrl":null,"url":null,"abstract":"Objective: To compare the efficacy and local adverse effects of Isoconazole Nitrate versus Nystatin for the treatment of patients having Otomycosis  Sudy Design: Group experimental study. Study Setting & Duration: Department of Otolaryngology, Head & Neck Surgery at Rawalpindi Teaching Hospital, Rawalpindi.  Duration of study was 6 months after approval by Ethical Committee from Feb 2023 to july 2023 Materials and Methods: Total of 64 patients were selected.  The study participants were individuals who, according to operational definitions had Otomycosis and who had presented for evaluation at the Department of Otolaryngology Rawalpindi teaching Hospital, Rawalpindi. They also met all inclusion and exclusion criteria requirements and these requirements were strictly adhered to in order to control confounders and bias. Isoconazole nitrate ointment was used to treat patients in Group A and Nystatin ointment was used to treat instances in Group B.  Patients were chosen by randomization using lottery method. SPSS 28 was used to determine the frequencies in the data. Results: 64 individuals (32 cases in each group) were chosen for the study by the ENT outpatient clinic. Out of which 33 (51.6%) being female and 31 (48.1) being male. The age ranged from 12 to 80 years, with a mean age of 44.29 ±19.13. After two weeks, there was a substantial improvement in 25 (39.06%) of the group A patients (p=0.08), a moderate improvement in 7 (10.9%), and a minor improvement in 5 (7.81%) patients (p=0.37) while in group B exhibited a substantial improvement in just 19 (10.9%) (p=0.08), a moderate improvement in 9 (39.0%) (p=0.38), and a small improvement in 7 (42.19%) (p=0.37). After four weeks 21 (32.81%) in Group B showed insignificant improvement, while 26 (40.63%) in Group A exhibited better improvement than Group B. The treatment for group A, which included isoconazole nitrate, was substantially more successful than the Nystatin treatment for group B. Isoconazole was found insignificantly more effective than   (p=0.08). The  majority of patients in both groups didn't notice any adverse  . Conclusion: Nystatin was shown to be significantly less efficacious than isoconazole nitrate ointment in treating otomycosis.","PeriodicalId":34174,"journal":{"name":"Journal of Rawalpindi Medical College","volume":"38 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rawalpindi Medical College","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37939/jrmc.v27i3.2372","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To compare the efficacy and local adverse effects of Isoconazole Nitrate versus Nystatin for the treatment of patients having Otomycosis  Sudy Design: Group experimental study. Study Setting & Duration: Department of Otolaryngology, Head & Neck Surgery at Rawalpindi Teaching Hospital, Rawalpindi.  Duration of study was 6 months after approval by Ethical Committee from Feb 2023 to july 2023 Materials and Methods: Total of 64 patients were selected.  The study participants were individuals who, according to operational definitions had Otomycosis and who had presented for evaluation at the Department of Otolaryngology Rawalpindi teaching Hospital, Rawalpindi. They also met all inclusion and exclusion criteria requirements and these requirements were strictly adhered to in order to control confounders and bias. Isoconazole nitrate ointment was used to treat patients in Group A and Nystatin ointment was used to treat instances in Group B.  Patients were chosen by randomization using lottery method. SPSS 28 was used to determine the frequencies in the data. Results: 64 individuals (32 cases in each group) were chosen for the study by the ENT outpatient clinic. Out of which 33 (51.6%) being female and 31 (48.1) being male. The age ranged from 12 to 80 years, with a mean age of 44.29 ±19.13. After two weeks, there was a substantial improvement in 25 (39.06%) of the group A patients (p=0.08), a moderate improvement in 7 (10.9%), and a minor improvement in 5 (7.81%) patients (p=0.37) while in group B exhibited a substantial improvement in just 19 (10.9%) (p=0.08), a moderate improvement in 9 (39.0%) (p=0.38), and a small improvement in 7 (42.19%) (p=0.37). After four weeks 21 (32.81%) in Group B showed insignificant improvement, while 26 (40.63%) in Group A exhibited better improvement than Group B. The treatment for group A, which included isoconazole nitrate, was substantially more successful than the Nystatin treatment for group B. Isoconazole was found insignificantly more effective than   (p=0.08). The  majority of patients in both groups didn't notice any adverse  . Conclusion: Nystatin was shown to be significantly less efficacious than isoconazole nitrate ointment in treating otomycosis.
硝酸异康唑与硝酸萘丁胺治疗耳霉菌病的比较
目的比较硝酸异康唑与奈替汀治疗耳霉菌病患者的疗效和局部不良反应:分组实验研究。研究地点和时间拉瓦尔品第拉瓦尔品第教学医院耳鼻咽喉头颈外科。 经伦理委员会批准,研究时间为 6 个月,从 2023 年 2 月至 2023 年 7 月:共选择了 64 名患者。 根据操作定义,研究对象为患有耳霉菌病并到拉瓦尔品第市拉瓦尔品第教学医院耳鼻喉科接受评估的患者。他们还符合所有纳入和排除标准的要求,并严格遵守这些要求,以控制混杂因素和偏差。A 组患者使用硝酸异康唑软膏治疗,B 组患者使用奈司他丁软膏治疗。使用 SPSS 28 确定数据的频率。结果耳鼻喉科门诊选取了 64 名患者(每组 32 例)进行研究。其中女性 33 人(51.6%),男性 31 人(48.1%)。年龄从 12 岁到 80 岁不等,平均年龄为(44.29 ± 19.13)岁。两周后,A 组中有 25 名(39.06%)患者的病情得到明显改善(P=0.08),7 名(10.9%)患者的病情得到中度改善,5 名(7.81%)患者的病情得到轻微改善(P=0.37),而 B 组中仅有 19 名(10.9%)患者的病情得到明显改善(P=0.08),9 名(39.0%)患者的病情得到中度改善(P=0.38),7 名(42.19%)患者的病情得到轻微改善(P=0.37)。四周后,B 组有 21 人(32.81%)的病情改善不明显,而 A 组有 26 人(40.63%)的病情改善优于 B 组。两组中的大多数患者均未发现任何不良反应。结论在治疗耳霉菌病方面,奈司他丁的疗效明显低于硝酸异康唑软膏。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
2
审稿时长
24 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信